Title |
Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial
|
---|---|
Published in |
Lancet Oncology, May 2012
|
DOI | 10.1016/s1470-2045(12)70138-9 |
Pubmed ID | |
Authors |
Bryan H Burmeister, Michael A Henderson, Jill Ainslie, Richard Fisher, Juliana Di Iulio, B Mark Smithers, Angela Hong, Kerwin Shannon, Richard A Scolyer, Scott Carruthers, Brendon J Coventry, Scott Babington, Joao Duprat, Harald J Hoekstra, John F Thompson |
Abstract |
The use of radiotherapy after therapeutic lymphadenectomy for patients with melanoma at high risk of further lymph-node field and distant recurrence is controversial. Decisions for radiotherapy in this setting are made on the basis of retrospective, non-randomised studies. We did this randomised trial to assess the effect of adjuvant radiotherapy on lymph-node field control in patients who had undergone therapeutic lymphadenectomy for metastatic melanoma in regional lymph nodes. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 2 | 22% |
Japan | 1 | 11% |
United States | 1 | 11% |
Unknown | 5 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 89% |
Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | 2% |
Brazil | 2 | <1% |
Ecuador | 2 | <1% |
Germany | 1 | <1% |
United Kingdom | 1 | <1% |
France | 1 | <1% |
Unknown | 282 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 59 | 20% |
Other | 44 | 15% |
Student > Master | 26 | 9% |
Student > Ph. D. Student | 25 | 9% |
Student > Postgraduate | 25 | 9% |
Other | 67 | 23% |
Unknown | 48 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 183 | 62% |
Agricultural and Biological Sciences | 14 | 5% |
Nursing and Health Professions | 7 | 2% |
Biochemistry, Genetics and Molecular Biology | 6 | 2% |
Psychology | 4 | 1% |
Other | 15 | 5% |
Unknown | 65 | 22% |